Your search returned 3 results.

Results
	1.	Pharmacokinetics of pyrazinamide during the initial phase of tuberculous meningitis treatment. [electronic resource] by Stemkens, R Litjens, C H C Dian, S Ganiem, A R Yunivita, V van Crevel, R Te Brake, L H M Ruslami, R Aarnoutse, R E Producer: 20191231 In: International journal of antimicrobial agents vol. 54 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Exposure to total and protein-unbound rifampin is not affected by malnutrition in Indonesian tuberculosis patients. [electronic resource] by te Brake, L H M Ruslami, R Later-Nijland, H Mooren, F Teulen, M Apriani, L Koenderink, J B Russel, F G Burger, D M Alisjahbana, B Wieringa, F van Crevel, R Aarnoutse, R E Producer: 20160216 In: Antimicrobial agents and chemotherapy vol. 59 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Pharmacokinetics, Tolerability, and Bacteriological Response of Rifampin Administered at 600, 900, and 1,200 Milligrams Daily in Patients with Pulmonary Tuberculosis. [electronic resource] by Aarnoutse, R E Kibiki, G S Reither, K Semvua, H H Haraka, F Mtabho, C M Mpagama, S G van den Boogaard, J Sumari-de Boer, I M Magis-Escurra, C Wattenberg, M Logger, J G M Te Brake, L H M Hoelscher, M Gillespie, S H Colbers, A Phillips, P P J Plemper van Balen, G Boeree, M J Producer: 20180611 In: Antimicrobial agents and chemotherapy vol. 61 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)